1380. Safety of Repurposed Drugs for Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: An Analysis of Adverse Events Reported in the Literature

por Stone, Heather, Duggal, Mili, Sacks, Leonard, Ghosh, Mayurika
Publicado 2019

Collaborative Use Repurposing Engine (CURE): FDA-NCATS/NIH Effort to Capture the Global Clinical Experience of Drug Repurposing to Facilitate Development of New Treatments for Negl...

por Stone, Heather, Sacks, Leonard, Tiernan, Rosemary, Duggal, Mili, Sheils, Timothy, Southall, Noel
Publicado 2017

546. Capturing Clinician’s Experiences Repurposing Drugs to Inform Future Studies During COVID-19

por Duggal, Mili, Stone, Heather, Paul, Parvesh, Charles, Reema, Sacks, Leonard, Southall, Noel
Publicado 2020

627. CURE ID as a Tool for Curating and Analyzing Drugs Used in COVID-19 Clinical Trials

por Charles, Reema, Paul, Parvesh, Stone, Heather, Gorobet, Serghei, Nhundu, Belinda, Borkowski, Katarzyna M, Duggal, Mili, Tirupathi, Raghavendra
Publicado 2021